Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Lilly | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Lilly

U.S. patent expirations hurt results

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lilly

4Q Revenues: $5.1 billion (-12%)

4Q Earnings: $428.5 (-41%)

FY Revenues: $19.6 billion (-15%)

FY Earnings: $2.4 billion (-49%)

Comments: Results were impacted by U.S. patent expirations for Cymbalta (-58% to $367 million in 4Q14) and Evista (-74% to $72 million in 4Q14) and the unfavorable impact of foreign exchange rates. Alimta sales were flat at $725 million in the quarter. Humalog sales were $729 million (-1%). Cialis sales were up 6% to $622 million. Humulin sales were $396 million, up 7%. Forteo sales were up 6% to $381 million. Zyprexa sales were down 27% to $253 million. U.S. revenue decreased 19% to $2.5 billion, due to patent expirations. Revenue outside the U.S. decreased 3% to $2.7 billion, primarily due to unfavorable exchange rates. In the quarter, the company recognized acquired in-process R&D charges of $105.2 million associated with revisions to its agreement with Boehringer Ingelheim, and its collaboration with Adocia. On January 1, 2015, the company completed the acquisition of Novartis Animal Health for approximately $5.4 billion in cash.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters